Andrew Spokes portfolio, Q2 2025
Farallon Capital Management · 13F for the quarter ending Jun 30, 2025
For Q2 2025, Farallon Capital Management reported $21.9B across 143 US-listed positions, led by SPY (15.5%), MSFT (4.0%) and NTRA (3.7%). Compared with its filing for Q1 2025, Andrew Spokes opened 17 new positions, added to 38, reduced 30 and sold out of 18; 57 positions did not change.
The largest purchase was a new position in SPY ($3.4B); the largest sale, the sale of the whole position in Discover Finl Svcs ($815.9M).
Key facts
- 13F portfolio value
- $21.9BQ2 2025
- Positions
- 143
- Largest holding
- SPY 15.5%
- New positions
- 17
- Sold out
- 18
- Filed
- Aug 14, 2025
Holdings as of (Q2 2025), filed with the SEC on and amended on . Changes are measured against the filing for Mar 31, 2025. Every tracked investor's Q2 2025 13F.
Bought and sold in Q2 2025
| Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|
| SPDR S&P 500 ETFSPY | ▲ New | +5.5M | $3.4B | 15.5% |
Discover Finl Svcsno ticker on file | ▼ Sold out | −4.78M | $815.9M | 3.72% |
| Amazon.com IncAMZN | ▲ New | +3.03M | $665.8M | 3.04% |
Intra-Cellular Therapies Incno ticker on file | ▼ Sold out | −3.06M | $403M | 1.84% |
| Exelixis IncEXEL | ▼ Reduced 29% | −6.5M | $286.4M | 1.31% |
| Microsoft CorpMSFT | ▼ Reduced 24% | −538K | $267.6M | 1.22% |
| IntuitINTU | ▼ Reduced 36% | −303.6K | $239.1M | 1.09% |
| Aon PLCAON | ▲ Added 46% | +624.67K | $222.9M | 1.02% |
| New York Times Co MTN BeNYT | ▼ Reduced 37% | −3.32M | $186M | 0.85% |
| Mckesson CorpMCK | ▼ Reduced 43% | −237.9K | $174.3M | 0.79% |
| Sarepta Therapeutics IncSRPT | ▼ Sold out | −2.34M | $149.4M | 0.68% |
| Thermo Fisher Scientific IncTMO | ▲ Added 34% | +347.39K | $140.9M | 0.64% |
| AramarkARMK | ▼ Reduced 21% | −3.34M | $139.9M | 0.64% |
Kellanovano ticker on file | ▼ Reduced 47% | −1.56M | $123.8M | 0.56% |
| Woodward IncWWD | ▼ Reduced 36% | −505.03K | $123.8M | 0.56% |
| Biohaven LtdBHVN | ▼ Sold out | −4.81M | $115.7M | 0.53% |
Azek Co Incno ticker on file | ▲ Added 176% | +2M | $108.8M | 0.50% |
| Bridgebio Pharma IncBBIO | ▲ Added 38% | +2.17M | $93.7M | 0.43% |
| Tenet Healthcare CorpTHC | ▲ New | +529K | $93.1M | 0.42% |
United States Stl Corpno ticker on file | ▼ Sold out | −2.14M | $90.2M | 0.41% |
| Somnigroup International IncSGI | ▼ Sold out | −1.33M | $79.4M | 0.36% |
| Autodesk IncADSK | ▼ Reduced 13% | −252.75K | $78.2M | 0.36% |
| The Walt Disney CoDIS | ▼ Reduced 11% | −621.96K | $77.1M | 0.35% |
| iShares Bitcoin Trust ETFIBIT | ▲ Added 21% | +1.23M | $75.1M | 0.34% |
| IQVIA Holdings IncIQV | ▲ Added 13% | +439.5K | $69.3M | 0.32% |
| Full Truck Alliance CoYMM | ▼ Reduced 79% | −5.81M | $68.6M | 0.31% |
Verona Pharma Plcno ticker on file | ▲ Added 67% | +725.01K | $68.6M | 0.31% |
| WabtecWAB | ▼ Reduced 19% | −299.9K | $62.8M | 0.29% |
| Visa IncV | ▼ Reduced 35% | −165.4K | $58.7M | 0.27% |
| GE HealthCare Technologies IncGEHC | ▲ Added 146% | +785K | $58.1M | 0.27% |
| Waystar Holding CorpWAY | ▼ Reduced 70% | −1.41M | $57.5M | 0.26% |
| Lantheus Holdings IncLNTH | ▲ Added 12% | +699K | $57.2M | 0.26% |
| CBRE Group IncCBRE | ▼ Reduced 15% | −382.56K | $53.6M | 0.24% |
Hess Corpno ticker on file | ▲ Added 7.0% | +380K | $52.6M | 0.24% |
| Natera IncNTRA | ▲ Added 6.0% | +274K | $46.3M | 0.21% |
| Surgery Partners IncSGRY | ▲ New | +1.93M | $42.8M | 0.20% |
JD.com Incno ticker on file | ▲ New | — | $41.8M | 0.19% |
| Salesforce IncCRM | ▲ Added 7.2% | +142K | $38.7M | 0.18% |
| UnitedHealth Group IncUNH | ▲ Added 8.0% | +119.4K | $37.2M | 0.17% |
| Nasdaq IncNDAQ | ▼ Reduced 8.4% | −376.55K | $33.7M | 0.15% |
Championx Corporationno ticker on file | ▲ Added 46% | +1.34M | $33.3M | 0.15% |
| Ultragenyx PharmaceuticalRARE | ▲ New | +898K | $32.7M | 0.15% |
| Oscar Health IncOSCR | ▲ Added more than 10× | +1.47M | $31.4M | 0.14% |
| Cardinal Health IncCAH | ▲ Added 66% | +181K | $30.4M | 0.14% |
Verve Therapeutics Incno ticker on file | ▲ Added 296% | +2.7M | $30.3M | 0.14% |
| Revolution Medicines IncRVMD | ▲ Added 5.8% | +791K | $29.1M | 0.13% |
| Mastercard IncMA | ▼ Reduced 24% | −49.3K | $27.7M | 0.13% |
| Abbott LabsABT | ▼ Reduced 59% | −197K | $26.8M | 0.12% |
| Grail IncGRAL | ▲ New | +502K | $25.8M | 0.12% |
| Boston Scientific CorpBSX | ▲ Added 5.8% | +218.3K | $23.4M | 0.11% |
| Tango Therapeutics IncTNGX | ▲ Added 99% | +4.55M | $23.3M | 0.11% |
| Schrodinger IncSDGR | ▲ New | +1.11M | $22.3M | 0.10% |
| Capricor Therapeutics IncCAPR | ▼ Reduced 98% | −2.21M | $21.9M | 0.10% |
| Alkermes PLCALKS | ▼ Reduced 50% | −698.14K | $20M | 0.09% |
MR Cooper Group Incno ticker on file | ▲ New | +122.5K | $18.3M | 0.08% |
Paramount Globalno ticker on file | ▲ New | +1.35M | $17.4M | 0.08% |
ANSYS Incno ticker on file | ▲ Added 5.2% | +49.13K | $17.3M | 0.08% |
| Flutter Entertainment PLCFLUT | ▼ Reduced 25% | −60.24K | $17.2M | 0.08% |
| Alphabet IncGOOG | ▲ Added 5.8% | +95.8K | $17M | 0.08% |
| Analog Devices IncADI | ▼ Reduced 4.1% | −54.8K | $13M | 0.06% |
| Hims & Hers Health IncHIMS | ▲ Added 3.3% | +259.88K | $13M | 0.06% |
| Beta Bionics IncBBNX | ▲ Added 26% | +871.7K | $12.7M | 0.06% |
| The Charles Schwab CorpSCHW | ▲ Added 3.3% | +126.2K | $11.5M | 0.05% |
| Encompass Health CorpEHC | ▲ Added 14% | +89K | $10.9M | 0.05% |
| Healthequity IncHQY | ▼ Reduced 24% | −102K | $10.7M | 0.05% |
Juniper Networks Incno ticker on file | ▼ Sold out | −295K | $10.7M | 0.05% |
| Latam Airlines Group SALTM | ▼ Reduced 43% | −243.92K | $9.9M | 0.05% |
Cidara Therapeutics Incno ticker on file | ▲ New | +200K | $9.7M | 0.04% |
| New Oriental ED & TechnologyEDU | ▼ Reduced 11% | −150K | $8.1M | 0.04% |
| Globus Med IncGMED | ▲ Added 153% | +127K | $7.5M | 0.03% |
| Voyager Therapeutics IncVYGR | ▼ Reduced 72% | −1.86M | $5.8M | 0.03% |
Springworks Therapeutics Incno ticker on file | ▼ Reduced 96% | −113K | $5.3M | 0.02% |
Amedisys Incno ticker on file | ▲ Added 9.5% | +50K | $4.9M | 0.02% |
| Zymeworks IncZYME | ▼ Sold out | −400K | $4.8M | 0.02% |
| RxSight IncRXST | ▼ Sold out | −175K | $4.4M | 0.02% |
| Vnet Group IncVNET | ▲ Added 23% | +555K | $3.8M | 0.02% |
| Protagonist Therapeutics IncPTGX | ▲ Added 1.1% | +65K | $3.6M | 0.02% |
| Liquidia CorporationLQDA | ▲ Added 6.2% | +247.81K | $3.1M | 0.01% |
Centessa Pharmaceuticals PLCno ticker on file | ▲ Added 4.5% | +195K | $2.6M | 0.01% |
| Agios Pharmaceuticals IncAGIO | ▲ Added 1.2% | +67K | $2.2M | 0.01% |
| GeneDx Holdings CorpWGS | ▲ Added 7.8% | +23.68K | $2.2M | 0.01% |
Marblegate Acquisition Corpno ticker on file | ▼ Sold out | −150K | $1.7M | 0.01% |
| Silicon Motion Technology CoSIMO | ▼ Sold out | −29.3K | $1.5M | 0.01% |
| Beam Therapeutics IncBEAM | ▲ Added 0.9% | +85K | $1.4M | 0.01% |
| Livanova PLCLIVN | ▼ Reduced 84% | −31K | $1.4M | 0.01% |
Crinetics Pharmaceuticalsno ticker on file | ▲ Added 0.9% | +41K | $1.2M | 0.01% |
| Tvardi Therapeutics IncTVRD | ▲ New | +43.23K | $1M | 0.00% |
Liberty Broadband Corpno ticker on file | ▲ Added 16% | +8.22K | $803.6K | 0.00% |
| TransUnionTRU | ▼ Reduced 0.2% | −8.63K | $759.5K | 0.00% |
Cara Therapeutics Incno ticker on file | ▼ Sold out | −129.69K | $657.5K | 0.00% |
Forte Biosciences Incno ticker on file | ▼ Sold out | −70.43K | $546.5K | 0.00% |
| Biodesix IncBDSX | ▼ Reduced 93% | −1.73M | $488.6K | 0.00% |
| Guardant Health IncGH | ▲ New | +8K | $416.3K | 0.00% |
| JOYY IncJOYY | ▲ Added 1.0% | +7.91K | $402.5K | 0.00% |
Blueprint Medicines Corpno ticker on file | ▼ Sold out | −4K | $354K | 0.00% |
| Chemed CorpCHE | ▼ Sold out | −400 | $246.1K | 0.00% |
Marblegate Acquisition Corpno ticker on file | ▼ Sold out | −1.49M | $237.6K | 0.00% |
Akero Therapeutics Incno ticker on file | ▲ New | +4K | $213.4K | 0.00% |
| CG Oncology IncCGON | ▲ New | +8K | $208K | 0.00% |
| Transmedics Group IncTMDX | ▼ Sold out | −3K | $201.8K | 0.00% |
| Travere Therapeutics IncTVTX | ▲ New | +12K | $177.6K | 0.00% |
| Elanco Animal Health IncELAN | ▼ Sold out | −16K | $168K | 0.00% |
Third Harmonic Bio Incno ticker on file | ▲ New | +15.36K | $83.4K | 0.00% |
Holdings at the quarter's end
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Held | Since Q1 2025 |
|---|---|---|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETFSPY · TR UNIT | — | 15.5% | $3.4B | 5.5M | $617.85 | 1 qtr | New |
| 2 | Microsoft CorpMSFT | Technology | 3.96% | $869.4M | 1.75M | $497.41 | 4+ qtrs | ▼ Reduced 24% |
| 3 | Natera IncNTRA | Health Care | 3.71% | $814.6M | 4.82M | $168.94 | 4+ qtrs | ▲ Added 6.0% |
| 4 | Hess Corpno ticker on file | — | 3.67% | $804.2M | 5.81M | $138.54 | 4+ qtrs | ▲ Added 7.0% |
| 5 | Aon PLCAON · SHS CL A | Financials | 3.23% | $708.7M | 1.99M | $356.76 | 4+ qtrs | ▲ Added 46% |
| 6 | Exelixis IncEXEL | Health Care | 3.22% | $706.8M | 16.04M | $44.08 | 4+ qtrs | ▼ Reduced 29% |
| 7 | Amazon.com IncAMZN | Consumer Discretionary | 3.04% | $665.8M | 3.03M | $219.39 | 1 qtr | New |
| 8 | IQVIA Holdings IncIQV | Health Care | 2.77% | $606.9M | 3.85M | $157.59 | 4+ qtrs | ▲ Added 13% |
| 9 | The Walt Disney CoDIS | Communication | 2.76% | $604.5M | 4.87M | $124.01 | 4+ qtrs | ▼ Reduced 11% |
| 10 | Salesforce IncCRM | Technology | 2.62% | $575.1M | 2.11M | $272.69 | 4+ qtrs | ▲ Added 7.2% |
| 11 | Thermo Fisher Scientific IncTMO | Health Care | 2.56% | $560.8M | 1.38M | $405.46 | 4+ qtrs | ▲ Added 34% |
| 12 | Lantheus Holdings IncLNTH | Health Care | 2.51% | $550.3M | 6.72M | $81.86 | 4+ qtrs | ▲ Added 12% |
| 13 | AramarkARMK | Consumer Discretionary | 2.46% | $540.1M | 12.9M | $41.87 | 4+ qtrs | ▼ Reduced 21% |
| 14 | Autodesk IncADSK | Technology | 2.46% | $540.1M | 1.74M | $309.57 | 3 qtrs | ▼ Reduced 13% |
| 15 | Revolution Medicines IncRVMD | Health Care | 2.40% | $527M | 14.33M | $36.79 | 4+ qtrs | ▲ Added 5.8% |
| 16 | UnitedHealth Group IncUNH | Health Care | 2.30% | $504.5M | 1.62M | $311.97 | 4+ qtrs | ▲ Added 8.0% |
| 17 | TransUnionTRU | Industrials | 2.17% | $475.6M | 5.4M | $88.00 | 4+ qtrs | ▼ Reduced 0.2% |
| 18 | iShares Bitcoin Trust ETFIBIT · SHS BEN INT | — | 1.96% | $429.7M | 7.02M | $61.21 | 4+ qtrs | ▲ Added 21% |
| 19 | Boston Scientific CorpBSX | Health Care | 1.95% | $427.6M | 3.98M | $107.41 | 4+ qtrs | ▲ Added 5.8% |
| 20 | IntuitINTU | Technology | 1.93% | $422.7M | 536.66K | $787.63 | 4+ qtrs | ▼ Reduced 36% |
| 21 | Liberty Broadband Corpno ticker on file | — | 1.92% | $420.5M | 4.27M | $98.38 | 4+ qtrs | No change |
| 22 | Hims & Hers Health IncHIMS | Health Care | 1.87% | $409.4M | 8.21M | $49.85 | 4+ qtrs | ▲ Added 3.3% |
| 23 | Nasdaq IncNDAQ | Financials | 1.67% | $365.2M | 4.08M | $89.42 | 4+ qtrs | ▼ Reduced 8.4% |
| 24 | The Charles Schwab CorpSCHW | Financials | 1.65% | $361.2M | 3.96M | $91.24 | 3 qtrs | ▲ Added 3.3% |
| 25 | ANSYS Incno ticker on file | — | 1.60% | $350.2M | 997.13K | $351.22 | 4+ qtrs | ▲ Added 5.2% |
| 26 | Protagonist Therapeutics IncPTGX | Health Care | 1.56% | $341.1M | 6.17M | $55.27 | 4+ qtrs | ▲ Added 1.1% |
| 27 | Bridgebio Pharma IncBBIO | Health Care | 1.56% | $341.1M | 7.9M | $43.18 | 4+ qtrs | ▲ Added 38% |
| 28 | New York Times Co MTN BeNYT · CL A | Communication | 1.43% | $314M | 5.61M | $55.98 | 4+ qtrs | ▼ Reduced 37% |
| 29 | Alphabet IncGOOG · CAP STK CL C | — | 1.43% | $312.5M | 1.76M | $177.39 | 4+ qtrs | ▲ Added 5.8% |
| 30 | Analog Devices IncADI | Technology | 1.38% | $302.8M | 1.27M | $238.02 | 4+ qtrs | ▼ Reduced 4.1% |
| 31 | CBRE Group IncCBRE · CL A | Real Estate | 1.35% | $296.1M | 2.11M | $140.12 | 4+ qtrs | ▼ Reduced 15% |
| 32 | WabtecWAB | Industrials | 1.25% | $273.9M | 1.31M | $209.35 | 4+ qtrs | ▼ Reduced 19% |
| 33 | Mckesson CorpMCK | Health Care | 1.05% | $230.5M | 314.6K | $732.78 | 3 qtrs | ▼ Reduced 43% |
| 34 | Woodward IncWWD | Industrials | 1.02% | $224.2M | 914.67K | $245.09 | 4+ qtrs | ▼ Reduced 36% |
| 35 | Agios Pharmaceuticals IncAGIO | — | 0.88% | $191.8M | 5.77M | $33.26 | 4+ qtrs | ▲ Added 1.2% |
| 36 | Verona Pharma Plcno ticker on file · SPONSORED ADS | — | 0.78% | $171.2M | 1.81M | $94.58 | 2 qtrs | ▲ Added 67% |
| 37 | Azek Co Incno ticker on file · CL A | — | 0.78% | $170.7M | 3.14M | $54.35 | 2 qtrs | ▲ Added 176% |
| 38 | Beam Therapeutics IncBEAM | — | 0.78% | $170.3M | 10.01M | $17.01 | 4+ qtrs | ▲ Added 0.9% |
| 39 | Kellanovano ticker on file | — | 0.64% | $140.2M | 1.76M | $79.53 | 3 qtrs | ▼ Reduced 47% |
| 40 | Crinetics Pharmaceuticalsno ticker on file | — | 0.61% | $133.6M | 4.65M | $28.76 | 4+ qtrs | ▲ Added 0.9% |
| 41 | Visa IncV | Financials | 0.50% | $109.6M | 308.81K | $355.05 | 4+ qtrs | ▼ Reduced 35% |
| 42 | Championx Corporationno ticker on file | — | 0.48% | $105.4M | 4.25M | $24.84 | 4+ qtrs | ▲ Added 46% |
| 43 | GE HealthCare Technologies IncGEHC | Health Care | 0.45% | $97.9M | 1.32M | $74.07 | 3 qtrs | ▲ Added 146% |
| 44 | Tenet Healthcare CorpTHC | Health Care | 0.43% | $93.1M | 529K | $176.00 | 1 qtr | New |
| 45 | Encompass Health CorpEHC | Health Care | 0.40% | $86.8M | 708K | $122.63 | 4+ qtrs | ▲ Added 14% |
| 46 | Mastercard IncMA · CL A | Financials | 0.39% | $85.5M | 152.07K | $561.94 | 4+ qtrs | ▼ Reduced 24% |
| 47 | Cardinal Health IncCAH | Health Care | 0.35% | $76.3M | 454K | $168.00 | 2 qtrs | ▲ Added 66% |
| 48 | New Oriental ED & TechnologyEDU · SPON ADR | Consumer Discretionary | 0.28% | $62.3M | 1.16M | $53.95 | 4+ qtrs | ▼ Reduced 11% |
| 49 | Beta Bionics IncBBNX | — | 0.28% | $61.2M | 4.2M | $14.56 | 2 qtrs | ▲ Added 26% |
| 50 | Centessa Pharmaceuticals PLCno ticker on file · SPONSORED ADS | — | 0.27% | $59.5M | 4.53M | $13.14 | 4+ qtrs | ▲ Added 4.5% |
| 51 | Amedisys Incno ticker on file | — | 0.26% | $56.6M | 575K | $98.39 | 4+ qtrs | ▲ Added 9.5% |
| 52 | Liquidia CorporationLQDA | — | 0.24% | $52.8M | 4.24M | $12.46 | 4+ qtrs | ▲ Added 6.2% |
| 53 | Flutter Entertainment PLCFLUT · SHS | Technology | 0.24% | $51.8M | 181.23K | $285.76 | 4+ qtrs | ▼ Reduced 25% |
| 54 | Tango Therapeutics IncTNGX | — | 0.21% | $46.9M | 9.16M | $5.12 | 3 qtrs | ▲ Added 99% |
| 55 | Surgery Partners IncSGRY | — | 0.20% | $42.8M | 1.93M | $22.23 | 1 qtr | New |
| 56 | JD.com Incno ticker on file · NOTE 0.250% 6/0 | — | 0.19% | $41.8M | — | — | 1 qtr | New |
| 57 | Verve Therapeutics Incno ticker on file | — | 0.19% | $40.6M | 3.61M | $11.23 | 2 qtrs | ▲ Added 296% |
| 58 | JOYY IncJOYY · ADS REPSTG COM A | — | 0.18% | $40.1M | 787.91K | $50.91 | 2 qtrs | ▲ Added 1.0% |
| 59 | Healthequity IncHQY | Health Care | 0.15% | $33.5M | 319.8K | $104.76 | 4+ qtrs | ▼ Reduced 24% |
| 60 | Ultragenyx PharmaceuticalRARE | — | 0.15% | $32.7M | 898K | $36.36 | 1 qtr | New |
| 61 | Oscar Health IncOSCR · CL A | Health Care | 0.14% | $31.6M | 1.48M | $21.44 | 4+ qtrs | ▲ Added more than 10× |
| 62 | GeneDx Holdings CorpWGS | — | 0.14% | $30.2M | 326.68K | $92.31 | 3 qtrs | ▲ Added 7.8% |
| 63 | Grail IncGRAL | Health Care | 0.12% | $25.8M | 502K | $51.42 | 1 qtr | New |
| 64 | Waystar Holding CorpWAY | Technology | 0.11% | $25.1M | 613K | $40.87 | 3 qtrs | ▼ Reduced 70% |
| 65 | Schrodinger IncSDGR | — | 0.10% | $22.3M | 1.11M | $20.12 | 1 qtr | New |
| 66 | Vnet Group IncVNET · SPONSORED ADS A | — | 0.09% | $20.7M | 2.99M | $6.90 | 4+ qtrs | ▲ Added 23% |
| 67 | Alkermes PLCALKS · SHS | Health Care | 0.09% | $19.8M | 691.66K | $28.61 | 2 qtrs | ▼ Reduced 50% |
| 68 | Abbott LabsABT | Health Care | 0.08% | $18.5M | 136K | $136.01 | 2 qtrs | ▼ Reduced 59% |
| 69 | Full Truck Alliance CoYMM · SPONSORED ADS | Technology | 0.08% | $18.3M | 1.55M | $11.81 | 4+ qtrs | ▼ Reduced 79% |
| 70 | MR Cooper Group Incno ticker on file | — | 0.08% | $18.3M | 122.5K | $149.21 | 1 qtr | New |
| 71 | Paramount Globalno ticker on file · CLASS B COM | — | 0.08% | $17.4M | 1.35M | $12.90 | 1 qtr | New |
| 72 | Tectonic Therapeutic IncTECX | — | 0.08% | $17M | 853.05K | $19.87 | 4+ qtrs | No change |
| 73 | Enanta Pharmaceuticals IncENTA | — | 0.07% | $16M | 2.12M | $7.56 | 4+ qtrs | No change |
| 74 | Savara IncSVRA | — | 0.07% | $15.6M | 6.84M | $2.28 | 4+ qtrs | No change |
| 75 | Mara Holdings IncMARA | — | 0.06% | $13.1M | 835K | $15.68 | 3 qtrs | No change |
| 76 | Latam Airlines Group SALTM · SPONSORED ADR | Industrials | 0.06% | $12.9M | 318.09K | $40.64 | 4+ qtrs | ▼ Reduced 43% |
| 77 | Globus Med IncGMED · CL A | Health Care | 0.06% | $12.4M | 210K | $59.02 | 4+ qtrs | ▲ Added 153% |
| 78 | Nuvalent Incno ticker on file | — | 0.05% | $11.4M | 150K | $76.30 | 4+ qtrs | No change |
| 79 | Tyra Biosciences IncTYRA | — | 0.05% | $10.9M | 1.14M | $9.57 | 3 qtrs | No change |
| 80 | Cidara Therapeutics Incno ticker on file | — | 0.04% | $9.7M | 200K | $48.71 | 1 qtr | New |
| 81 | Helix Acquisition Corp IIHLXC · CL A ORD SHS | — | 0.03% | $6.4M | 600K | $10.65 | 4+ qtrs | No change |
| 82 | Liberty Broadband Corpno ticker on file | — | 0.03% | $5.7M | 58.22K | $97.82 | 2 qtrs | ▲ Added 16% |
| 83 | Voyager Therapeutics IncVYGR | — | 0.01% | $2.2M | 715K | $3.11 | 4+ qtrs | ▼ Reduced 72% |
| 84 | Prime Medicine IncPRME | — | 0.01% | $1.9M | 750K | $2.47 | 4+ qtrs | No change |
| 85 | Alvotech SAALVO · ORDINARY SHARES | — | 0.01% | $1.8M | 199.68K | $9.12 | 4+ qtrs | No change |
| 86 | Summit Midstream CorporationSMC | — | 0.01% | $1.4M | 58.21K | $24.53 | 4+ qtrs | No change |
| 87 | Janux Therapeutics IncJANX | — | 0.01% | $1.1M | 48K | $23.10 | 3 qtrs | No change |
| 88 | Tvardi Therapeutics IncTVRD | — | 0.01% | $1M | 43.23K | $23.33 | 1 qtr | New |
| 89 | Madrigal Pharmaceuticals IncMDGL | Health Care | 0.01% | $1M | 3.32K | $302.64 | 4+ qtrs | No change |
| 90 | Brightspring Health Services IncBTSG | Health Care | 0.00% | $519K | 22K | $23.59 | 4+ qtrs | No change |
| 91 | Soleno Therapeutics Incno ticker on file | — | 0.00% | $418.9K | 5K | $83.78 | 3 qtrs | No change |
| 92 | Axsome Therapeutics IncAXSM | Health Care | 0.00% | $417.6K | 4K | $104.39 | 4+ qtrs | No change |
| 93 | Roivant Sciences LtdROIV · SHS | Health Care | 0.00% | $417K | 37K | $11.27 | 4+ qtrs | No change |
| 94 | Guardant Health IncGH | Health Care | 0.00% | $416.3K | 8K | $52.04 | 1 qtr | New |
| 95 | Capricor Therapeutics IncCAPR | — | 0.00% | $407.1K | 41K | $9.93 | 3 qtrs | ▼ Reduced 98% |
| 96 | Progyny IncPGNY | — | 0.00% | $396K | 18K | $22.00 | 4+ qtrs | No change |
| 97 | Sage Therapeutics Incno ticker on file | — | 0.00% | $390.3K | 42.8K | $9.12 | 4+ qtrs | No change |
| 98 | Arcutis Biotherapeutics IncARQT | — | 0.00% | $364.5K | 26K | $14.02 | 4+ qtrs | No change |
| 99 | Insmed IncINSM | Health Care | 0.00% | $301.9K | 3K | $100.64 | 4+ qtrs | No change |
| 100 | Cencora IncCOR | Health Care | 0.00% | $299.9K | 1K | $299.85 | 4+ qtrs | No change |
| 101 | United Therapeutics CorpUTHR | Health Care | 0.00% | $287.4K | 1K | $287.35 | 4+ qtrs | No change |
| 102 | Twist Bioscience CorpTWST | Health Care | 0.00% | $281.4K | 7.65K | $36.79 | 4+ qtrs | No change |
| 103 | Merit Med Systems IncMMSI | Health Care | 0.00% | $280.4K | 3K | $93.48 | 4+ qtrs | No change |
| 104 | Krystal Biotech IncKRYS | Health Care | 0.00% | $274.9K | 2K | $137.46 | 4+ qtrs | No change |
| 105 | Livanova PLCLIVN · SHS | Health Care | 0.00% | $270.1K | 6K | $45.02 | 2 qtrs | ▼ Reduced 84% |
| 106 | Glaukos CorpGKOS | Health Care | 0.00% | $268.6K | 2.6K | $103.29 | 4+ qtrs | No change |
| 107 | Beone Medicines LtdONC · SPONSORED ADS | Health Care | 0.00% | $266.3K | 1.1K | $242.07 | 4+ qtrs | No change |
| 108 | Arcellx Incno ticker on file | — | 0.00% | $263.4K | 4K | $65.85 | 4+ qtrs | No change |
| 109 | Sabra Health Care REIT IncSBRA | Real Estate | 0.00% | $258.2K | 14K | $18.44 | 4+ qtrs | No change |
| 110 | Grifols S AGRFS · SP ADR REP B NVT | Health Care | 0.00% | $253.1K | 28K | $9.04 | 4+ qtrs | No change |
| 111 | Arrowhead PharmaceuticalsARWR | Health Care | 0.00% | $249.6K | 15.8K | $15.80 | 3 qtrs | No change |
| 112 | Scholar Rock Holding CorpSRRK | Health Care | 0.00% | $247.9K | 7K | $35.42 | 3 qtrs | No change |
| 113 | Ascendis Pharma A/SASND · SPONSORED ADR | Health Care | 0.00% | $241.6K | 1.4K | $172.60 | 2 qtrs | No change |
| 114 | Springworks Therapeutics Incno ticker on file | — | 0.00% | $235K | 5K | $46.99 | 2 qtrs | ▼ Reduced 96% |
| 115 | Aleanna Incno ticker on file · *W EXP 12/13/202 | — | 0.00% | $232.7K | 990K | $0.2350 | 3 qtrs | No change |
| 116 | Akero Therapeutics Incno ticker on file | — | 0.00% | $213.4K | 4K | $53.36 | 1 qtr | New |
| 117 | CG Oncology IncCGON | Health Care | 0.00% | $208K | 8K | $26.00 | 1 qtr | New |
| 118 | Bruker CorpBRKR | Health Care | 0.00% | $206K | 5K | $41.20 | 4+ qtrs | No change |
| 119 | Uniqure NVQURE · SHS | — | 0.00% | $195.2K | 14K | $13.94 | 2 qtrs | No change |
| 120 | Immunovant IncIMVT | Health Care | 0.00% | $192K | 12K | $16.00 | 4+ qtrs | No change |
| 121 | Healthcare Realty TrustHR · CL A COM | Real Estate | 0.00% | $190.3K | 12K | $15.86 | 4+ qtrs | No change |
| 122 | Travere Therapeutics IncTVTX | Health Care | 0.00% | $177.6K | 12K | $14.80 | 1 qtr | New |
| 123 | Pacific Biosciences of California IncPACB | — | 0.00% | $167.4K | 135K | $1.24 | 4+ qtrs | No change |
| 124 | Evolent Health IncEVH · CL A | — | 0.00% | $157.6K | 14K | $11.26 | 4+ qtrs | No change |
| 125 | Solid Power Incno ticker on file · *W EXP 12/08/202 | — | 0.00% | $152K | 405.32K | $0.3750 | 4+ qtrs | No change |
| 126 | Cogent Biosciences IncCOGT | Health Care | 0.00% | $122.1K | 17K | $7.18 | 4+ qtrs | No change |
| 127 | Altimmune IncALT | — | 0.00% | $106.8K | 27.6K | $3.87 | 4+ qtrs | No change |
| 128 | Novavax IncNVAX | — | 0.00% | $100.8K | 16K | $6.30 | 4+ qtrs | No change |
| 129 | Dyne Therapeutics IncDYN | — | 0.00% | $95.2K | 10K | $9.52 | 4+ qtrs | No change |
| 130 | Syndax Pharmaceuticals IncSNDX | — | 0.00% | $93.7K | 10K | $9.37 | 4+ qtrs | No change |
| 131 | Amicus Therapeuticno ticker on file | — | 0.00% | $91.7K | 16K | $5.73 | 4+ qtrs | No change |
| 132 | Ardelyx IncARDX | — | 0.00% | $90.2K | 23K | $3.92 | 4+ qtrs | No change |
| 133 | Third Harmonic Bio Incno ticker on file | — | 0.00% | $83.4K | 15.36K | $5.43 | 1 qtr | New |
| 134 | Beyond Meat IncBYND | — | 0.00% | $66.3K | 19K | $3.49 | 4+ qtrs | — |
| 135 | Geron CorpGERN | — | 0.00% | $60.6K | 43K | $1.41 | 4+ qtrs | No change |
| 136 | Aleanna Incno ticker on file | — | 0.00% | $49.8K | 78.4K | $0.6347 | 3 qtrs | No change |
| 137 | Iovance Biotherapeutics IncIOVA | — | 0.00% | $44.7K | 26K | $1.72 | 4+ qtrs | No change |
| 138 | C4 Therapeutics IncCCCC | — | 0.00% | $40K | 28K | $1.43 | 4+ qtrs | No change |
| 139 | Canopy Growth CorporationCGC | — | 0.00% | $36.6K | 30K | $1.22 | 4+ qtrs | No change |
| 140 | Biodesix IncBDSX | — | 0.00% | $36.1K | 128K | $0.2822 | 4+ qtrs | ▼ Reduced 93% |
| 141 | Revolution Medicines Incno ticker on file · *W EXP 12/17/202 | — | 0.00% | $32.4K | 120.09K | $0.2700 | 4+ qtrs | No change |
| 142 | Nvni Group Limitedno ticker on file · *W EXP 11/01/202 | — | 0.00% | $19.4K | 375K | $0.0516 | 4+ qtrs | No change |
| 143 | Ironwood Pharmaceuticals IncIRWD | — | 0.00% | $9.3K | 13K | $0.7172 | 4+ qtrs | No change |
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Health Care | 29.7% | $6.5B | 45 |
| Technology | 12.8% | $2.8B | 8 |
| Financials | 7.43% | $1.6B | 5 |
| Consumer Discretionary | 5.78% | $1.3B | 3 |
| Industrials | 4.50% | $986.6M | 4 |
| Communication | 4.19% | $918.5M | 2 |
| Real Estate | 1.35% | $296.5M | 3 |
| No sector on file | 34.2% | $7.5B | 73 |
Questions and answers
What did Andrew Spokes own in Q2 2025?
Farallon Capital Management's 13F for Q2 2025 lists 143 positions worth $21.9B. The largest: SPY (15.5%), MSFT (4.0%), NTRA (3.7%), Hess Corp (3.7%), AON (3.2%).
What did Andrew Spokes buy in Q2 2025?
The largest purchases, by the shares bought at the quarter-end price the filing implies: SPY (new, $3.4B), AMZN (new, $665.8M), AON (added, $222.9M), TMO (added, $140.9M), Azek Co Inc (added, $108.8M), BBIO (added, $93.7M).
What did Andrew Spokes sell in Q2 2025?
The largest sales: Discover Finl Svcs (sold out, $815.9M), Intra-Cellular Therapies Inc (sold out, $403M), EXEL (reduced, $286.4M), MSFT (reduced, $267.6M), INTU (reduced, $239.1M), NYT (reduced, $186M).
When was this filing made?
Farallon Capital Management filed its 13F for the quarter ending Jun 30, 2025 on Aug 14, 2025, and amended it on Feb 17, 2026; the figures here include the amendment. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.
Learn
Cite this page
Funkfolio, “Andrew Spokes portfolio, Q2 2025: Farallon Capital Management 13F holdings”, data as of 17 February 2026. https://funkfolio.com/gurus/farallon/2025-q2
Underlying data: SEC EDGAR, Form 13F-HR of Farallon Capital Management (CIK 909661) for the period ending Jun 30, 2025.
Source: SEC EDGAR, Form 13F-HR for Farallon Capital Management (CIK 909661), period ending Jun 30, 2025, filed Aug 14, 2025, amended Feb 17, 2026. Changes compare share counts with the filing for Mar 31, 2025; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $21.9B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 4 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. 2 option positions in the filing are not shown. Not a live portfolio and not advice.